It has been shown that DDX56 dysregulation is associated with squamous cell lung carcinoma 8, glioblastoma 9, osteosarcoma 10, and colorectal cancer 11, suggesting that DDX56 may play a critical role in cancer development and progression. Here, DDX56 is linked to osteosarcoma.